InsidersTradesSigma
Discover the full management transaction log of Lexaria Bioscience Corp., a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, Lexaria Bioscience Corp. has recorded 3 insider filings. Market capitalisation: €14.4m. The latest transaction was reported on 25 May 2022 — Attribution. Among the most active insiders: REESE ALBERT L JR. Every trade is accessible without an account.
FY ended August 2025 · cache
0 of 0 declarations